|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,056 GBX | -0.41% |
|
-2.43% | +13.74% |
| Jul. 05 | AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer | MT |
| Jul. 05 | AstraZeneca: cancer treatment approved by the EU | CF |
ASTRAZENECA: SAFETY PROFILE OF ENHERTU WAS CONSISTENT WITH PREVIOUS BREAST CANCER CLINICAL TRIALS WITH NO NEW SAFETY CONCERNS IDENTIFIED
| 1st Jan change | Capi. | |
|---|---|---|
| +13.74% | 239B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +15.99% | 320B | |
| +7.92% | 295B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B | |
| -2.57% | 159B |
ASTRAZENECA PLC 
